Feds Search for Person Responsible for Shipping Tainted Syringes

How to Prepare For Possible “Tripledemic” of RSV, Influenza, and SARS-CoV-2

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

NIH Announces HIV Vaccine Clinical Trial Begins

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

Poll: What Minimum Educational Requirement Should Infection Preventionists Have?

How to Prepare For Possible “Tripledemic” of RSV, Influenza, and SARS-CoV-2

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

NIH Announces HIV Vaccine Clinical Trial Begins

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

Poll: What Minimum Educational Requirement Should Infection Preventionists Have?

How to Prepare For Possible “Tripledemic” of RSV, Influenza, and SARS-CoV-2

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

NIH Announces HIV Vaccine Clinical Trial Begins

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

Poll: What Minimum Educational Requirement Should Infection Preventionists Have?

Related Content

(Adobe Stock FILE #: 56169337 by thinglass)

How to Prepare For Possible “Tripledemic” of RSV, Influenza, and SARS-CoV-2

Many infection preventionists (IPs) disagree on the minimum requirement to have the IP position. Let Infection Control Today know your opinion. Answer this poll, and send your thoughts to Senior Editor Tori Whitacre Martonicz at tmartonicz@mjhlifesciences.com.

Influenza, RSV, and COVID-19 (AdobeStock_249346161, AdobeStock_538653843,AdobeStock_471755796)

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

The interaction between the respiratory viruses SARS-CoV-2, influenza, and RSV, poses ongoing challenges. Personal protective measures, testing, and vaccination are critical components of our strategy to mitigate the impact of these viruses.

weekly rounds with infection control today

NIH Announces HIV Vaccine Clinical Trial Begins

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending September 24, 2023.

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy

A new preventative vaccine has been developed incorporating technology funded by the NIH since 2004. The trials will be conducted in the United States and South Africa.

Vial of COVID-19 vaccine, bottle for injection with syringe. (Adobe Stock 331786954 by myskin)

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

Randomized controlled trials show masks are effective. With COVID-19, even one mistake in protective gear usage could lead to infection and obscure results.

In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses COVID-19 vaccines and boosters, Legionella infections from transplants, and hospital leadership.